|
Home |
CMAJ on PMRA, November 2023 |
EV as empty vessel in car sewers, Eric Reguly, Globe & Mail, May 20, 2023 |
Comic Piccini opera, Redux, Ontario auditor general Env Report, Globe & Mail, May 18, 2023 |
Venal or Venial? letter to Globe, May 16, 2023 |
"Cry me a river over a few bats", Redux, Globe & Mail, May 12,2023 |
Greenbelt "Scam": Barbarian Ford invasions, Globe & Mail, May 12, 2023 |
Barbarian Ford invasions case: City of Belleville Bell Creek dvlpt, Intelligencer, April 25, 2023 |
Road building projects in Wales, UK, cancelled as climate clangers, the Guardian, Feb 14, 2023 |
Unpublshed letter to Globe, 1996 opioids revisited, February 6, 2023 |
Cathal Kelly on climate charade, Globe & Mail, January 27, 2023 |
Ontario Bill 23, letter to the Premier, and Todd Smith MPP, Nov 24, 2022 |
Canola conundrum, letter to Globe & Mail, October 2022 |
3rd (Canadian) arm of U.S. Air Pollution Health Effects Study, the Guardian, Aug 12, 2022 |
Atomic awe and Boris blight, letter to Globe, July 11, 2022 |
Your !!*^%! car, Part II, Globe and Mail editorial, July 16, 2022 |
Your !!*^%! car, Part I, Globe and Mail, June 20, 2022 |
CAPE report on fossil fuels, Globe and Mail, June 9, 2022 |
Traffic Air Pollution Health Effects report, CAPE, April 2022 |
EU Bans Toxics, the Guardian, April 2022 |
Comic Piccini opera: Ontario Auditor General Environment Report, November 2021 |
......RIP Trillium...... November 16, 2021 |
Covid-19 Parlour Sessions 2020/2021, April 1, 2021 |
Mitch Podoluk, Obituary, Globe and Mail, September 2019 |
Notice to (Big Bay) Mariners, August 2019 |
Air Head, Globe and Mail, August 2019 |
Leon Redbone, RIP, June 2019 |
Ontario Endangered Species Act at risk, letter to Rod Phillips, April 2019 |
Slide to Extinction, Chris Humphrey, letter to Globe, October 31, 2018 |
Peter Galbraith, FRCP, obituary, October 2017 |
White Pines on Death Bed, Bruce Bell, Intelligencer, July 17,2018 |
Thucydides Trap, letter to Globe, May 2018 |
Great Lakes toxics down, SUNY Oswego/Clarkson U, April 2018 |
Machine subversion of democracy, letter to Globe, April 2018 |
Air Pollution overrides Ancestral Genes, Globe, March 2018 |
Olympian Cathal Kelly, letter to Globe, March 2018 |
Environmentalists seeking unemployment, letter to Globe, February 2018 |
Less is more on Bike Lanes, National Post, January 2018 |
Tramadol, 10 years on, Globe and Mail, November 2017 |
White Stripes: Belleville bicycle lanes, letters, November 2017 |
Occupational Cancers, CCO research results, Globe and Mail, October 2017 |
Big Pharmoney and Canadian Drug Use Guidelines, Globe and Mail, June 21, 2017, Kelly Grant |
Oxycontin, 20 years on, letter to Globe, May 2017 |
Lake Ontario wind turbines to remain on hold? Feb 2017 |
Obituary, Raold Serebrin, September 2016 |
Sartorial slip or signal? letter to Globe editor, October 2016 |
Weapons of mass distraction, letter to Globe editor, Oct 2016 |
Point O turbines 99% Down the Drain, CCSAGE, July 7, 2016 |
Point O turbines Dead and Damned, PECFN, July 6, 2016 |
Rabid diplomat, letter to Globe, May, 2016 |
More on bats: rabid rocker? letter to Globe, January 2016 |
Lighthouses of eastern Lake Ontario, new book by Marc Seguin, March 2016 |
Continuing corporate windpower malfeasance: Windstream and Trillium Corp, Feb 2016 |
Amherst Island: the next fine mess, Feb 2016 |
Valerie Langer: Thirty years of effort pays off on the B.C. coast, Feb 1,2016 |
Trillium log, 6th annual ELO expedtion, September 2015 |
Trillium Wind Corp intent on Spoliation of eastern Lake Ontario and Main Duck Isle, June 2015 |
Turtles rule? Ontario Court of Appeal Decision: Turtlegate, April 2015 |
Obituaries, Mary Terrance (Luke) Hill, January 2015; Valerie Ingrid (Hill) Kaldes, July 2015 |
Ontario Court of Appeal turtle hearing, December 2014 |
Trillium Log, 5th annual ELO expedition, September 2014 |
Planetary public health manifesto, The Lancet, March 2014 |
Ostrander Bioblitz, butterfly inventory walk, August 10, 2014 |
Victory at Cape Vincent: British Petroleum withdraws turbine proposal, February 2014 |
Stay of execution granted by Ontario Court of Appeal, March 2014 |
Never say die: Will the Court of Appeal let the Ostrander Phoenix fly free again? March 2014 |
Divisional Court ruling in Ostrander: turtles belly up, Trojan horses win, February 2014 |
Lafarge 2020, pushing the air envelope again, Hazardous waste as cement kiln fuel proposal, Jan2014 |
Another fine mess in Port Hope: municipal waste incinerator proposal, January 2014 |
Ostrander: fiasco, or snafu? you decide, December 2013 |
Ostrander rises again, Noli illegitimi carborundum, December 2013 |
British Petroleum backing off Cape Vincent after a decade of aggression? December 2013 |
Turbines best Bald Eagles in U.S law, December 2013 |
SARStock 10 years after, letter to Globe, August 2003 |
Trillium log September 2013: Surfin' USA: Hanging Ten in a Hughes 29 |
ERT Post mortem: Garth Manning lets it all hang out, August 2013 |
ERT post mortem: Cheryl Anderson lets it all hang out, August 2013 |
ERT Post Mortem: Ian Dubin lets it all hang out, August 2013 |
Great Lakes United turns thirty, goes down, RIP GLU, July 29, 2013 |
ERT decision, Ostrander turns turtle, goes down, July 3, 2013 |
PECFN Thankyou, and Appeal for funds, July 6, 2013 |
Minister of Env on Lake Ontario Off shore wind turbine status, June 2013 |
Lake Ontario water level control plan, June 2013 |
Play by Play, Part II, APPEC Ostrander ERT Appeal, June 2013 |
Ostrander ERT June 2013, Appendix VI, an indirect cause of human morbidity and mortality ? |
ELOERG Presentation to Ostrander ERT, Part II, Human Health, May 2013 |
The Dirty E-Word, Terry Sprague, Picton Gazette, April 2013 |
Toxics in Great Lakes Plastic Pollution, April 2013 |
Bill Evans on Birds and Wind farms, April 2013 |
Mayday, Naval Marine Archive, April 2013 |
Experimental Lakes Area, Kenora, Closing by Federal Gov't, March 2013 |
Fishing Lease Phase out on Prince Edward Point, March 2013 |
Windstream makes $1/2 Billion NAFTA claim, March 2013 |
Play by Play, PECFN Ostrander ERT Appeal, March 2013 |
Offshore Wind turbine moratorium 2 years later, The Star, Feb 2013 |
ELOERG ERT submission on Ostrander: Appendix V: Pushing the Envelope of the MoE SEV, Feb 2013 |
Wente on Wind and Bald Eagle mugging, Globe and Mail, February 2, 2013 |
Sprague on Wind and Bald Eagle mugging, Picton Gazette, Jan 25, 2013 |
Cry Me a River over a Few Bats: Submission to Env Review Tribunal, ELOERG, January 2013 |
Lake Ontario's Troubled Waters: U of Michigan GLEAM, January 2013 |
Letter to Minister of Environment re: Ostrander, January 2013 |
No Balm in Gilead: Ostrander IWT's as Trojan Horses, January 2013 |
Ostrander Turbines: another Christmas gift by the MoE, Dec 2012 |
Occupational carcinogens: Ontario Blue Collar breast cancer study, November 2012 |
Fresh water fish Extinctions, Scientific American,November 2012 |
Great Lakes Toxics revisited, November 2012 |
Frack the What ? November 2012 |
$ 2 1/4 Billion Trillium Power lawsuit knockback Appeal, November 2012 |
Canada Centre for Inland Waters decimated, October 2012 |
Birds, Bats, Turbines, and the Environmental Commissioner of Ontario, October 2012 |
Ecological public health, the 21st centurys big idea? British MedicalJournal Sept1,2012 |
Trillium log, Sept 2012 |
George Prevost, Saviour of the Canadas, 1812 - 1814. June 2012 |
The Victory at Picton: Bicentennial Conference on War of 1812-1814, Differing Perspectives, May 2012 |
Carleton Island and the 1812, letter to the Globe, October 2011 |
Queen's Fine Arts Department Succumbs, letter to Principal, December 2011 |
Mr. Kumar and the Super 30, November 2011 |
Letters, Articles and Projects from the Nineties |
Alban Goddard Hill, web site manager |
|
|
|
Enter subhead content here
|
|
Commentary
Open Access
Time to improve transparency at Health Canada’s Pest Management Regulatory Agency
Marc-André Gagnon and Marie-Hélène Bacon
CMAJ November 27, 2023 195 (46) E1583-E1584; DOI: https://doi.org/10.1503/cmaj.231089
ArticleResponsesMetrics
PDF
KEY POINTS
In the last year, Health Canada’s Pest Management Regulatory Agency has been criticized for not releasing
information about the safety of pesticides because data are considered confidential business information.
This level of secrecy contrasts with Health Canada’s efforts to improve transparency related to therapeutic
products.
Vanessa’s Law gives the federal Minister of Health discretionary powers to share confidential business information
on therapeutic products when it perceives there is a serious risk to human health or the environment.
The Minister of Health should be granted similar discretionary powers to make safety data for pesticides publicly
available.
In 2021, Health Canada’s Pest Management Regulatory Agency (PMRA) proposed doubling the maximum residue limits
for glyphosate in some food products, such as oats and beans.1 This proposal, made at Bayer-Monsanto’s request,2
raised serious concerns about the health impact of glyphosate-based herbicides (GBHs) in food consumed in Canada.
The most widely sold pesticides in Canada, GBHs are used on many crops, such as soybeans and corn, for grain desiccation
or to kill weeds. Several studies and a meta-analysis have shown their harmful health impacts.3,4 For example, after reviewing
independent scientific literature, the World Health Organization’s International Agency for Research on Cancer concluded
that both glyphosate and GBHs (which contain other chemicals in addition to glyphosate) are genotoxic and probable carcinogens
to humans and have a positive association with non-Hodgkin lymphoma.5 Nonetheless, Health Canada reapproved GBHs until 2032
and increased maximum residue limits above those in the United States and China. The PMRA considers that residues of glyphosate
“will not pose an unacceptable risk to any segment of the population.”1 When civil society group Vigilance
OGM submitted an Access to Information request to obtain the studies supporting that claim, PMRA sent, after 1 year, 229 totally
blank pages.6 When pushed for more transparency, Health Canada announced that it would create a new Science Advisory Committee
on Pest Control Products, comprising independent scientific advisors. In July 2023, the co-president of the committee, Bruce
Lanphear, resigned because of the committee’s inability to access product safety data, stating that he believed
the industry had too strong an influence over pesticide regulation.7
Dr. Lanphear’s resignation highlights problems with pesticide regulation by PMRA. Although the commercial formulations
of GBHs contain coformulants (e.g., polyethoxylated tallow amines, perfluoroalkyl and polyfluoroalkyl substances, arsenic,
petroleum) that increase toxicity by as much as 1000-fold compared with glyphosate alone, the PMRA assesses and regulates
only glyphosate as the “active” ingredient, which is highly problematic.7 Moreover, manufacturers’
data and information that are central to PMRA’s evaluation of pesticide safety are kept secret as “confidential
business information” (CBI) and therefore cannot be verified outside of PMRA. For example, the evaluation of the
toxicologic hazards of glyphosate in its reauthorization in 2017 was based, in the Proposed Re-Evaluation Decision, on 118
references to classified studies provided by industry and not subject to independent scientific peer review, and 7 “published”
references with no authors or places of publication identified.8
Health Canada’s PMRA considers pesticide risk evaluation and their sales data in Canada to be CBI, and independent
researchers cannot access these data, even through the Access to Information Act. Such a level of secrecy contrasts with important
steps taken by Health Canada to improve transparency of data about therapeutic products.
A culture of data secrecy and CBI is not new at Health Canada. For decades, Health Canada was considered proactive in
limiting access to safety data about pharmaceutical products, such as adverse drug reactions.9 In 2004, the Canadian Association
of Journalists declared Health Canada “the most secretive of government departments,” and awarded it the
“code of silence award” for its “remarkable zeal in suppressing information” and “concealing
vital data about dangerous drugs.’’9 Only after a media campaign by the Canadian Broadcasting Corporation
about the risks of therapeutic products did Health Canada finally take steps toward greater transparency on drug information,
and a database about existing adverse drug reactions was made publicly available online in 2005.
Health Canada also faced serious criticism for its lack of transparency regarding clinical trial data that were considered
CBI. Although drug companies submitted all their clinical data for drug approval, they selected the data that were made available
through medical publications, creating significant bias in drug information provided to prescribing physicians.10 However,
these harmful practices were considerably reduced after the passage of Bill C-17 in 2014, an Act to Amend the Food and Drugs
Act—Protecting Canadians from Dangerous Drugs Act, also known as Vanessa’s Law.11 After a slow implementation,
the transparency provisions of Vanessa’s Law have compelled drug companies to make publicly available certain information
about the clinical trials and other safety studies they sponsor. The law also gave the Minister of Health new discretionary
powers to share CBI without notice or consent from the party that claims ownership over that CBI, in particular if the minister
believes there is a serious risk to human health that could be mitigated or avoided (Canada Food and Drug Act, Art. 21.11–3).
Even when no such risk appears to exist, the minister still has the discretion to share CBI with anyone who “protects
or promotes human health” or public safety, as long as the person does not use the CBI for commercial purposes.
Since June 2023, the minister has also had the ability to share CBI of drug companies when the purpose is to protect the environment
(Canada Food and Drug Act, Art. 21.301), but the same minister still cannot use that power with respect to CBI of pesticide
companies.
The new discretionary powers outlined above allow the health minister to share these data with researchers on demand.11
They even allow for the implementation of a web portal via which the public can directly access all clinical data considered
for the approval of new medicines, greatly improving transparency for therapeutic products.11 However, these efforts have
been confined to therapeutic products, despite abundant scientific literature showing the association of pesticides with health
conditions, such as Parkinson disease, cognitive disorders, prostate cancer, multiple myeloma, and non-Hodgkin lymphoma, as
well as neuropsychological and motor development disorders, congenital malformations and leukemia in children exposed during
pregnancy.4
This ongoing culture of secrecy at Health Canada’s PMRA is deeply concerning. Health ministers should use their
discretionary powers to ensure that safety data for pesticides stop being concealed as CBI, as is the case for therapeutic
products. By restraining access to evidence and by imposing secrecy, Health Canada impedes constructive public debates over
important scientific and health issues related to pesticides, which nurtures the idea that governmental institutions are influenced
by the agrochemical industry.
Acknowledgement
The authors thank Louise Vandelac for her help in researching this article.
Footnotes
Competing interests: Marie-Hélène Bacon is on the board of directors (unpaid position) of the nonprofit organization
Vigilance OGM. No other competing interests were declared.
This article has been peer reviewed.
Contributors: Both authors contributed to the conception and design of the work, drafted the manuscript, revised it
critically for important intellectual content, gave final approval of the version to be published and agreed to be accountable
for all aspects of the work.
Funding: This commentary was supported by the Fonds de recherche du Québec — Société et culture (FRQSC)
(No. 254243), and by an Insight Grant from the Social Sciences and Humanities Research Council of Canada (SSHRC) (No. 435-2021-
0715). The funders had no role in the design, conduct, or publication of the content.
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND
4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly
cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
References
↵Proposed maximum residue limit PMRL2021-10, glyphosate. Ottawa: Health Canada; modified 2021 Nov. 12. Available:
https://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-maximum-residue-limit/2021/glyphosate/document.html
(accessed 2022 Dec. 14).
Google Scholar
↵
Gerbet T. Glyphosate: c’est le géant Bayer qui a demandé au Canada de revoir les limites. Radio Canada
2021 July 23. Available: https://ici.radio-canada.ca/nouvelle/1811085/glyphosate-bayer-canada-limites-pesticides-legumineuses
(accessed 2023 Aug. 28).
Google Scholar
↵
Zhang L, Rana I, Shaffer RM, et al. Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma:
a meta-analysis and supporting evidence. Mutat Res Rev Mutat Res 2019;781:186–206.
CrossRefPubMedGoogle Scholar
↵Pesticides et santé — Nouvelles données. Paris (France): Inserm; 2021. Available: https://www.inserm.fr/expertise-collective/pesticides-et-sante-nouvelles-donnees-2021/
(accessed 2023 Oct. 20).
Google Scholar
↵Some organophosphate insecticides and herbicides. In: IARC Monographs on the Evaluation of Carcinogenic
Risks to Humans. Vol. 12. Lyon (France): International Agency for Research on Cancer; 2017. Available: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Organophosphate-Insecticides-And-Herbicides-2017
(accessed 2022 Dec. 14).
Google Scholar
↵
Bacon M-H, Vandelac L, Gagnon M-A, et al. Poisoning regulation, research, health, and the environment: the glyphosate-based
herbicides case in Canada. Toxics 2023;11:121.
Google Scholar
↵
Gerbet T. Pesticides: démission « révélatrice » d’un scientifique nommé par Ottawa. Radio Canada 2023
July 18. Available: https://ici.radio-canada.ca/nouvelle/1996698/pesticides-demission-scientifique-comite-arla-ottawa (accessed
2023 July 25).
Google Scholar
↵
Vandelac L, Bacon M-H. Avis d’objection à la décision de réévaluation RDV2017- 01 sur le Glyphosate.
Montréal: CREPPA, Université du Québec à Montréal; 2017:1–23. Available: https://creppa.uqam.ca/wp-content/uploads/sites/105/Avis-dopposition-ARLA-glyphosate-Vandelac-Bacon-juin-2017.pdf
(accessed 2023 Oct. 20).
Google Scholar
↵
Lexchin J. Private profits versus public policy: the pharmaceutical industry and the Canadian state. Toronto:
University of Toronto Press; 2016.
Google Scholar
↵
Goldacre B. Bad pharma: how drug companies mislead doctors and harm patients. New York: Farrar, Straus and Giroux;
2014.
Google Scholar
↵
Gagnon M-A, Herder M, Graham J, et al. Clinical trial data transparency in Canada: mapping the progress from laggard
to leader. In: Transparency, Power, and Influence in the Pharmaceutical Industry. Halifax: Dalhousie University; 2021:114–28.
Available: https://www.sciencegate.app/document/10.3138/9781487529055-005 (accessed 2022 Dec. 14)
|
|
|
|
|
|
|
|
Enter supporting content here
Eastern Lake Ontario Environmental Research Group
|
|
|
|